Skip to NavigationSkip to content

News

AstraZeneca's schizophrenia drug Seroquel could provide a further sales boost for the company after new data indicated its efficacy in treating...
The pharmaceutical industry's negative view of PR has persuaded healthcare agency Jo Spink Public Relations to re-brand itself as Spink Consumer...
Abbott Labs' human monoclonal antibody Humira has received a positive opinion from the EMEA for the treatment of rheumatoid arthritis, the first such...
Pfizer's follow up to its multi-billion dollar painkiller Celebrex has been approved for marketing across the European Union following a lengthy...
AstraZeneca is bracing itself for what could be a make-or-break FDA ruling on its 'superstatin' blockbuster candidate Crestor.
Mental health charity MIND has criticised the way the Medicines Control Agency handles drug regulation, saying "it is playing Russian roulette with...
Mental health and primary care trusts could eventually take on foundation status, according to Health Secretary Alan Milburn.
Allied Health Professionals are to be encouraged to play a greater role in prescribing as part of a new government drive to increase their...
Omeprazole, the blockbuster ulcer drug discovered by AstraZeneca, could soon be dispensed by pharmacists without a prescription, pending final...
Eli Lilly has been publicly reprimanded for bringing the pharmaceutical industry into disrepute after promoting its erectile dysfunction treatment...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches